MEDMIRA INC (MIR.CA) Stock Fundamental Analysis

TSX-V:MIR • CA58501R1029

0.07 CAD
+0.01 (+7.69%)
Last: Feb 10, 2026, 07:00 PM
Fundamental Rating

1

MIR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 15 industry peers in the Health Care Equipment & Supplies industry. MIR has a bad profitability rating. Also its financial health evaluation is rather negative. MIR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • MIR had negative earnings in the past year.
  • In the past year MIR has reported a negative cash flow from operations.
  • MIR had negative earnings in each of the past 5 years.
  • MIR had a negative operating cash flow in each of the past 5 years.
MIR.CA Yearly Net Income VS EBIT VS OCF VS FCFMIR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1M -2M -3M -4M -5M

1.2 Ratios

  • MIR has a Return On Assets of -112.27%. This is in the better half of the industry: MIR outperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -112.27%
ROE N/A
ROIC N/A
ROA(3y)-83.65%
ROA(5y)-63.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MIR.CA Yearly ROA, ROE, ROICMIR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

1.3 Margins

  • With an excellent Gross Margin value of 69.66%, MIR belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
  • MIR's Gross Margin has improved in the last couple of years.
  • MIR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.07%
GM growth 5Y2.92%
MIR.CA Yearly Profit, Operating, Gross MarginsMIR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

0

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, MIR has about the same amount of shares outstanding.
  • The number of shares outstanding for MIR has been increased compared to 5 years ago.
  • The debt/assets ratio for MIR is higher compared to a year ago.
MIR.CA Yearly Shares OutstandingMIR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
MIR.CA Yearly Total Debt VS Total AssetsMIR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

  • Based on the Altman-Z score of -45.11, we must say that MIR is in the distress zone and has some risk of bankruptcy.
  • MIR has a Altman-Z score of -45.11. This is in the lower half of the industry: MIR underperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -45.11
ROIC/WACCN/A
WACCN/A
MIR.CA Yearly LT Debt VS Equity VS FCFMIR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5M -10M -15M -20M

2.3 Liquidity

  • A Current Ratio of 0.06 indicates that MIR may have some problems paying its short term obligations.
  • With a Current ratio value of 0.06, MIR is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.06 indicates that MIR may have some problems paying its short term obligations.
  • MIR's Quick ratio of 0.06 is on the low side compared to the rest of the industry. MIR is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
MIR.CA Yearly Current Assets VS Current LiabilitesMIR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

0

3. Growth

3.1 Past

  • The earnings per share for MIR have decreased by -5.45% in the last year.
  • MIR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.64%.
  • MIR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -23.52% yearly.
EPS 1Y (TTM)-5.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.84%
Revenue 1Y (TTM)-34.64%
Revenue growth 3Y-36.79%
Revenue growth 5Y-23.52%
Sales Q2Q%-12.16%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MIR.CA Yearly Revenue VS EstimatesMIR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MIR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MIR.CA Price Earnings VS Forward Price EarningsMIR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MIR.CA Per share dataMIR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.01 -0.02 -0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • MIR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MEDMIRA INC

TSX-V:MIR (2/10/2026, 7:00:00 PM)

0.07

+0.01 (+7.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)12-31
Earnings (Next)03-30
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.37%
Ins Owner ChangeN/A
Market Cap53.08M
Revenue(TTM)233.00K
Net Income(TTM)-4.04M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 227.82
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.03
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -112.27%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.66%
FCFM N/A
ROA(3y)-83.65%
ROA(5y)-63.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.07%
GM growth 5Y2.92%
F-Score2
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z -45.11
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.64%
Revenue growth 3Y-36.79%
Revenue growth 5Y-23.52%
Sales Q2Q%-12.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-49.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.56%
OCF growth 3YN/A
OCF growth 5YN/A

MEDMIRA INC / MIR.CA FAQ

What is the fundamental rating for MIR stock?

ChartMill assigns a fundamental rating of 1 / 10 to MIR.CA.


Can you provide the valuation status for MEDMIRA INC?

ChartMill assigns a valuation rating of 0 / 10 to MEDMIRA INC (MIR.CA). This can be considered as Overvalued.


How profitable is MEDMIRA INC (MIR.CA) stock?

MEDMIRA INC (MIR.CA) has a profitability rating of 2 / 10.


What is the financial health of MEDMIRA INC (MIR.CA) stock?

The financial health rating of MEDMIRA INC (MIR.CA) is 0 / 10.